Profilo
Jeff Macdonald is currently Executive Director-Investor Relations at Jazz Pharmaceuticals Plc and will hold the same title at Vaxcyte, Inc. starting in 2025.
Former roles include Senior Director-Corporate Communications at Acorda Therapeutics, Inc. and Senior Director-Investor Relations at G1 Therapeutics, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Washington & Lee University.
Posizioni attive di Jeff Macdonald
| Società | Posizione | Inizio |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Contatto Relazioni con gli Investitori | - |
| VAXCYTE, INC. | Contatto Relazioni con gli Investitori | 01/06/2025 |
Precedenti posizioni note di Jeff Macdonald
| Società | Posizione | Fine |
|---|---|---|
| G1 THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 04/01/2021 |
| ACORDA THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 10/05/2012 |
Formazione di Jeff Macdonald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
















